SLAYBACK PHARMA

VIVIMUSTA

  1. Home
  2.  / 
  3. J Code
  4.  / VIVIMUSTA – J9056

Manufacturer:

SLAYBACK PHARMA

Name:

VIVIMUSTA

HCPCS Code Descriptor:

Injection, bendamustine hydrochloride (vivimusta), 1 mg

Category:

J Code

HCPCS:

J9056

NDC(s):

71225-0120-01

Primary Type:

Oncology

Generic Status:

Single-Source

Route of Administration:

Intravenous

About:

VIVIMUSTA is a Oncology drug manufactured by SLAYBACK PHARMA and administered via the Intravenous route of administration. The J Code: J9056 is aligned to the drug VIVIMUSTA.

VIVIMUSTA is a chemotherapy cancer medication that belongs to the class of drugs known as alkylating antineoplastic agent. This medication attaches to the alkyl group in the cells DNA slowing down and stopping the growth of the cancer cells. VIVIMUSTA is manufactured by Slayback pharmaceuticals and is aligned to the HCPCS code J9056.

Access Pricing and More By Registering

HCPCS Added Date:

7/1/23

HCPCS Effective Date:

7/1/23

HCPCS Short Description:

Inj, bendamustine, 1 mg

Billing and Coding Guide:

Not Found

Patient Assistance:

Not Found

VIVIMUSTA - J9056